Antimalarial flow synthesis closer to commercialisation | Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Feeds:: Posts; Comments

Antimalarial flow synthesis closer to commercialisation

October 26, 2014 by larryhbern

Antimalarial flow synthesis closer to commercialisation.

Posted in Advanced Drug Manufacturing Technology, Antimalarial Preparation, CE Mark & Global Regulatory Affairs: process management and strategic planning - GCP, Cell Biology, Chemical Biology and its relations to Metabolic Disease, Commercialization, Curation, Disease Biology, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Experimental validation, FDA, CE Mark & Global Regulatory Affairs: process management and strategic planning - GCP, GLP, ISO 14155, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, International Global Work in Pharmaceutical, Investment in Technological Breakthrough, ISO 10993 for Product Registration: FDA & CE Mark for Development of Medical Devices and Diagnostics, Technology Advance Assessment of | Tagged antimalarial, artemisin, drud preparation, flow chemistry, Malaria | Leave a Comment

Leave a ReplyCancel reply